Literature DB >> 22281874

Antiviral CD8⁺ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice.

Jane E Libbey1, Matthew F Cusick, Ikuo Tsunoda, Robert S Fujinami.   

Abstract

Major histocompatibility complex class I-restricted CD8(+) cytotoxic T lymphocytes are involved in the pathogenesis of multiple sclerosis (MS) and both autoimmune, experimental autoimmune encephalomyelitis, and viral, Theiler's murine encephalomyelitis virus (TMEV) infection, animal models of MS. Following TMEV infection, certain T cell hybridomas, generated from cloned TMEV-induced CD8(+) T cells, were able to produce clinical signs of disease (flaccid hind limb paralysis) upon adoptive transfer into naive mice. Dual T cell receptors (TCR) are present on the surface of these cells as both Vβ3 and Vβ6 were detected by polymerase chain reaction (PCR) screening and flow cytometry and multiple Vα mRNAs were detected by PCR screening. This is the first demonstration of antiviral CD8(+) T cells having more than one TCR initiating an autoimmune disease in the natural host of the virus. We hypothesize that this is a potential mechanism for virus-induced autoimmune disease initiated by CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281874      PMCID: PMC3327473          DOI: 10.1007/s13365-012-0077-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  32 in total

1.  Characterization of a T suppressor cell line that downgrades experimental allergic encephalomyelitis in mice.

Authors:  W Ofosu-Appiah; F Mokhtarian
Journal:  Cell Immunol       Date:  1991-06       Impact factor: 4.868

2.  T-cell receptor alpha-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains.

Authors:  P A Singer; R J McEvilly; R S Balderas; F J Dixon; A N Theofilopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 3.  T-lymphocyte subsets in the multiple sclerosis lesion.

Authors:  R A Sobel
Journal:  Res Immunol       Date:  1989-02

4.  Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.

Authors:  M Rodriguez; S Sriram
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

5.  Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens.

Authors:  T Hayashi; C Morimoto; J S Burks; C Kerr; S L Hauser
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

6.  T cell subsets in multiple sclerosis. Gradients at plaque borders and differences in nonplaque regions.

Authors:  K McCallum; M M Esiri; W W Tourtellotte; J Booss
Journal:  Brain       Date:  1987-10       Impact factor: 13.501

7.  Expression of two T cell receptor alpha chains: dual receptor T cells.

Authors:  E Padovan; G Casorati; P Dellabona; S Meyer; M Brockhaus; A Lanzavecchia
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

Review 8.  Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

Authors:  H L Weiner; A Friedman; A Miller; S J Khoury; A al-Sabbagh; L Santos; M Sayegh; R B Nussenblatt; D E Trentham; D A Hafler
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.

Authors:  M D Lindsley; M Rodriguez
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

10.  Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

Authors:  M Rodriguez; J Leibowitz; C S David
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 2.  Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

Authors:  Ana Beatriz DePaula-Silva; Tyler J Hanak; Jane E Libbey; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2017-02-12       Impact factor: 3.478

3.  Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: implications for how viral infections might trigger multiple sclerosis exacerbations.

Authors:  Emily K Rainey-Barger; Pennelope K Blakely; Amanda K Huber; Benjamin M Segal; David N Irani
Journal:  J Neuroimmunol       Date:  2013-04-18       Impact factor: 3.478

Review 4.  Autoimmunity in picornavirus infections.

Authors:  Chandirasegaran Massilamany; Andreas Koenig; Jay Reddy; Sally Huber; Iwona Buskiewicz
Journal:  Curr Opin Virol       Date:  2015-11-08       Impact factor: 7.090

5.  Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis.

Authors:  Seiichi Omura; Fumitaka Sato; Nicholas E Martinez; Ah-Mee Park; Mitsugu Fujita; Nikki J Kennett; Urška Cvek; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 6.  Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.